Recommendation for validation and quality assurance of non‐invasive prenatal testing for foetal blood groups and implications for <scp>IVD</scp> risk classification according to <scp>EU</scp> regulationsFrederik Banch Clausen, Tobias J. Legler, Åsa Hellberg et al.|Vox Sanguinis|2021Cited by 21
Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in CyprusThessalia Papasavva, Marina Kleanthous, George Anastasiou et al.|BMC Research Notes|2016Cited by 14